Shanghai Seminar on US, Mexico & Japan IVF: Leading Experts Decode Fertility Challenges with Global One-Stop Fertility Solutions

On July 5, 2026, IVF USA, together with Mexico's POWER IVF Fertility Center, hosted a major in-person seminar in Shanghai focusing on overseas assisted reproduction, including IVF and egg freezing in Mexico, the United States, and Japan. The event focused on the key concerns of older single women and older families planning third-party assisted reproduction overseas. Three internationally renowned reproductive medicine experts were invited to provide in-depth discussions on fertility preservation, health protection, and family wealth succession.

During the seminar, the official IVF USA team not only provided an in-depth analysis of the rigorous quality control systems behind international embryology laboratories, but also addressed the real fertility concerns and common misconceptions faced by older and single women through extensive live Q&A sessions, offering attendees an evidence-based medical education experience that bridged the information gap.

01

From "Asset Protection" to the Foundation of Reproductive Technology

One case discussed involved a mother with assets exceeding one hundred million RMB, who had previously held a serious discussion with her 25-year-old son about planning the next generation of heirs for the family. Faced with the choice between using his own genetic material matched with healthy donor samples from distinguished cultural backgrounds (such as high-quality Jewish donor resources) to continue the family lineage, or having an older family member assume that responsibility, the young heir made his decision without hesitation, choosing to personally carry the family's legacy forward. This example reflects how elite families increasingly recognize the importance of long-term genetic planning. Within modern high-net-worth family risk management, fertility planning has already become a long-term "defensive life investment." Supporting this level of planning depends fundamentally on the quality control systems of international multi-center embryology laboratories. To illustrate this, two leading experts were introduced during the seminar.

Chief Scientist Dr. Weihua Wang:

Dr. Wang is internationally recognized as a leading authority in reproductive laboratory management and embryology. For 25 consecutive years, he participated in and managed the Houston Fertility Institute (HFI), one of the top five reproductive centers in the United States. He was directly responsible for establishing quality systems across more than 20 embryology laboratories and played a key role in building one of the largest egg banks in the United States. His work has achieved true technological leadership in cell cryopreservation and specimen banking.

POWER IVF Medical Director Dr. Gaytan:

Dr. Gaytan is one of Latin America's leading authorities in third-party reproduction management. He spent six years with Spain's IVI Group, one of the world's largest reproductive medicine organizations. Later, as Partner and Medical Director of IVI Mexico, he transformed the center into one of the largest and most successful fertility centers in Latin America over seven years. The center was subsequently invested in by the globally recognized reproductive media company controlled by renowned Japanese embryologist Dr. Kuwayama, inventor of vitrification technology.

During the seminar, Dr. Wang and Dr. Gaytan emphasized that affluent families should never judge a fertility center or physician based solely on promotional materials. Instead, they should carefully evaluate comprehensive performance data throughout every stage of the treatment process.

02

Critical Reproductive Decisions for Older and Single Women

During the Q&A session, several women facing important fertility decisions shared the real challenges they had encountered during their fertility journeys.

One 38-year-old woman and another 43-year-old woman (AMH 0.36, AFC 3) explained that they had previously undergone multiple mild stimulation cycles at traditional Japanese fertility clinics, retrieving only one or two eggs per cycle. After accumulating eleven eggs, they were uncertain whether continuing the same approach was worthwhile.

Dr. Wang explained that mild stimulation protocols use fewer medications but also retrieve fewer eggs per cycle. For older women, freezing individual eggs creates a highly uncertain situation because thawing and fertilization later involve significant attrition.

For women aged 35 to 38 and older who still have approximately eight to ten antral follicles, repeatedly choosing mild stimulation may ultimately result in medication exposure comparable to standard stimulation while significantly extending the overall IVF timeline and wasting valuable reproductive years. Dr. Wang emphasized that older women should let go of perfectionism, adopt a "You gotta get the job done" mindset, choose standard stimulation protocols, and prioritize freezing genetically screened Day 5 embryos.

Day 3 or Day 5 Embryos? AI Embryo Selection and Advances in Epigenetics

One attendee asked whether the laboratory transfers Day 3 or Day 5 embryos and whether artificial intelligence is involved in embryo selection.

Dr. Wang explained that the Mexico clinic exclusively cultures embryos to the Day 5 blastocyst stage because of their greater developmental stability. The laboratory system now combines artificial intelligence with traditional morphological assessment to improve embryo grading accuracy. In addition, POWER IVF collaborates with scientists from the Chinese Academy of Sciences to implement cutting-edge epigenetic testing technologies.

How Should Patients With a 0.4 mm Endometrium or Low AMH at Age 35 Make Decisions?

One attendee expressed concern about having an endometrial thickness of only 0.4 mm, while another asked whether a 35-year-old woman with low AMH but otherwise normal reproductive indicators should still pursue treatment.

POWER IVF specialists explained that although a 0.4 mm endometrium is indeed extremely thin, treatment options for improving uterine conditions are considerably broader than those available for ovarian function. Rather than proceeding directly with embryo transfer, physicians generally recommend individualized endometrial preparation using hormone therapy or medical approaches such as PRP before attempting embryo transfer.

For a 35-year-old woman with low AMH, specialists emphasized that egg quality generally remains favorable because of her age, making timely treatment worthwhile. However, single women selecting donor samples should never rely on chance but instead depend on rigorous medical evaluation and well-established legal procedures.

Do Ovarian Stimulation Medications Cause Significant Side Effects or Weight Gain?

Addressing one of the most common concerns among women, the experts responded directly:

"If you're an older woman approaching your fertility deadline, the only question should be whether temporary weight gain could help you have a healthy child."

Standard ovarian stimulation typically lasts only 10 to 12 days using subcutaneous injections. The hormones are naturally metabolized and eliminated by the body within a short period and do not cause permanent weight gain, premature ovarian failure, or cancer. Women should completely let go of these concerns.

This discussion again reflected how elite families increasingly regard fertility planning as a long-term defensive investment. Regardless of how much success individuals have achieved professionally or financially, biological realities remain unchanged. Using science proactively to preserve reproductive opportunities has become an essential component of long-term family planning.

03

An Integrated Cross-Border Fertility Network

After explaining the medical foundations, the seminar introduced IVF USA's integrated Japan-United States-Mexico multi-center fertility network designed for families pursuing international reproductive care.

Japan Multi-Center Network:

Japan offers highly refined laboratory techniques, convenient travel, and short flight times, making it especially suitable for older and single women who wish to efficiently complete egg freezing close to home while minimizing time costs.

United States Multi-Center Network:

The United States offers some of the world's most advanced reproductive technologies and one of the strongest legal frameworks, making it the preferred choice for families seeking top-tier medical care and comprehensive legal protection.

Mexico Multi-Center Network:

Mexico provides highly inclusive reproductive policies. Following the Mexican Supreme Court's landmark ruling in 2021, assisted reproductive services entered a new era of legal development. Single individuals and diverse family structures are clearly protected by law.

Mexico also permits the legal international transportation of reproductive tissues worldwide. As one of the host countries of the upcoming FIFA World Cup and an advanced economy, Mexico offers safe and attractive districts such as Roma Norte and Polanco. Comprehensive fertility treatment costs are approximately one-third of those in the United States, providing families with exceptional flexibility when designing personalized reproductive plans.

The successful conclusion of this seminar not only helped high-net-worth families gain a clearer understanding of global fertility planning but also enabled attendees to move beyond many common misconceptions. Moving forward, IVF USA will continue leveraging its international network of fertility centers across the United States, Mexico, and Japan, together with comprehensive legal support and world-class medical resources, to help independent women and older families build healthier futures while supporting the long-term preservation of both family health and wealth.